Graphene as Cancer Theranostic Tool: Progress and Future Challenges

被引:199
|
作者
Orecchioni, Marco [1 ]
Cabizza, Roberto [1 ]
Bianco, Alberto [2 ]
Delogu, Lucia Gemma [1 ]
机构
[1] Univ Sassari, Dept Chem & Pharm, I-07100 Sassari, Italy
[2] CNRS, Inst Biol Mol & Cellulaire, Lab Immunol Pathol & Chim Therapeut, F-67000 Strasbourg, France
来源
THERANOSTICS | 2015年 / 5卷 / 07期
关键词
graphene; nanomedicine; carbon materials; cancer; tumor; theranostics; therapy; FUNCTIONALIZED CARBON NANOTUBES; GUIDED PHOTOTHERMAL THERAPY; IN-VITRO EVALUATION; DRUG-DELIVERY; NANO-GRAPHENE; PHOTODYNAMIC THERAPY; NANOGRAPHENE OXIDE; ANTICANCER DRUG; CONJUGATED GRAPHENE; MESOPOROUS SILICA;
D O I
10.7150/thno.11387
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Nowadays cancer remains one of the main causes of death in the world. Current diagnostic techniques need to be improved to provide earlier diagnosis and treatment. Traditional therapy approaches to cancer are limited by lack of specificity and systemic toxicity. In this scenario nanomaterials could be good allies to give more specific cancer treatment effectively reducing undesired side effects and giving at the same time accurate diagnosis and successful therapy. In this context, thanks to its unique physical and chemical properties, graphene, graphene oxide (GO) and reduced graphene (rGO) have recently attracted tremendous interest in biomedicine including cancer therapy. Herein we analyzed all studies presented in literature related to cancer fight using graphene and graphene-based conjugates. In this context, we aimed at the full picture of the state of the art providing new inputs for future strategies in the cancer theranostic by using of graphene. We found an impressive increasing interest in the material for cancer therapy and/or diagnosis. The majority of the works (73%) have been carried out on drug and gene delivery applications, following by photothermal therapy (32%), imaging (31%) and photodynamic therapy (10%). A 27% of the studies focused on theranostic applications. Part of the works here discussed contribute to the growth of the theranostic field covering the use of imaging (i.e. ultrasonography, positron electron tomography, and fluorescent imaging) combined to one or more therapeutic modalities. We found that the use of graphene in cancer theranostics is still in an early but rapidly growing stage of investigation. Any technology based on nanomaterials can significantly enhance their possibility to became the real revolution in medicine if combines diagnosis and therapy at the same time. We performed a comprehensive summary of the latest progress of graphene cancer fight and highlighted the future challenges and the innovative possible theranostic applications.
引用
收藏
页码:710 / 723
页数:14
相关论文
共 50 条
  • [1] Peptides as Diagnostic, Therapeutic, and Theranostic Tools: Progress and Future Challenges
    Thakur, Reena
    Suri, Chander Raman
    Kaur, Indu Pal
    Rishi, Praveen
    [J]. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2023, 40 (01): : 49 - 100
  • [2] The application of nanoparticles in theranostic systems targeting breast cancer stem cells: current progress and future challenges
    Lin, Xinyu
    Wang, Ying
    Fang, Kai
    Guo, Zijian
    Lin, Nan
    Li, Lihua
    [J]. STEM CELL RESEARCH & THERAPY, 2023, 14 (01)
  • [3] The application of nanoparticles in theranostic systems targeting breast cancer stem cells: current progress and future challenges
    Xinyu Lin
    Ying Wang
    Kai Fang
    Zijian Guo
    Nan Lin
    Lihua Li
    [J]. Stem Cell Research & Therapy, 14
  • [4] Pancreatic Cancer: Current Progress and Future Challenges
    Hussain, S. Perwez
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2016, 12 (03): : 270 - 272
  • [5] Zebrafish models of cancer: progress and future challenges
    Yen, Jennifer
    White, Richard M.
    Stemple, Derek L.
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2014, 24 : 38 - 45
  • [6] Nanotechnology for the theranostic opportunity of breast cancer lung metastasis: recent advancements and future challenges
    Miao, Lin
    Kang, Yue
    Zhang, Xin Feng
    [J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2024, 12
  • [7] APOMAB AS A THERANOSTIC TOOL IN CANCER TREATMENT
    Staudacher, Alex
    [J]. INTERNAL MEDICINE JOURNAL, 2023, 53 : 46 - 46
  • [8] The Future of Childhood Cancer Survivorship Challenges and Opportunities for Continued Progress
    Dixon, Stephanie B.
    Chow, Eric J.
    Hjorth, Lars
    Hudson, Melissa M.
    Kremer, Leontien C. M.
    Morton, Lindsay M.
    Nathan, Paul C.
    Ness, Kirsten K.
    Oeffinger, Kevin C.
    Armstrong, Gregory T.
    [J]. PEDIATRIC CLINICS OF NORTH AMERICA, 2020, 67 (06) : 1237 - 1251
  • [9] miRNAs as colorectal cancer biomarkers: current progress and future challenges
    Hogan, Niamh M.
    Joyce, Myles R.
    Kerin, Michael J.
    [J]. COLORECTAL CANCER, 2013, 2 (05) : 419 - 427
  • [10] PROGRESS WITH CONSCIENCE - CHALLENGES FOR FUTURE
    COULTER, JB
    [J]. AGRICULTURAL ENGINEERING, 1972, 53 (10): : 19 - &